Acute abdomen secondary to perforated jejunal gastrointestinal stromal tumor and imatinib-related isolated pericardial effusion in a 50-year-old female patient: A case report and review of literature

Surgical management of a locally advanced jejunal stromal tumor: A case report of a challenging condition

“…These side effects will adversely affect the patient's short and long-term prognosis [ 10 ]. In addition, before prescribing imatinib in the neoadjuvant course for 6 to 12 months, the risks of major complications related to spontaneous evolution of the jejunal GIST (rupture, perforation, and hemorrhage) must be considered [ [11] , [12] , [13] ]. Finally, whereas locally advanced jejunal GISTs have shown similarities with their analogs in the stomach, clinical evolution appears to be less favorable [ 14 , 15 ].…”

“…The presence of GISTs in the jejunum is typically characterized by a minimal occurrence of lymph invasion and recurrence. As a result, there is no necessity for lymph node harvesting or systematic oncological resection when treating these small bowel tumors [ 12 ]. In our case, the jejunal GIST was locally advanced and we did not have histological proof of the tumor's nature.…”